Hongkongers to pay only HK$240 a year for leukaemia drug after system shake-up
- Posted on May 6, 2026
- By South China Morning Post
- 0 Views
- 1 min read
Hongkongers to pay only HK$240 a year for leukaemia drug after system shake-up
Hospital Authority says it began subsidising Dasatinib in April, with patients previously paying up to HK$500,000 annually for treatment.
